Logo image of AREN

ARENA GROUP HOLDINGS INC/THE (AREN) Stock Fundamental Analysis

NYSEARCA:AREN - NYSE Arca - US0400441095 - Common Stock - Currency: USD

5.76  -0.34 (-5.57%)

After market: 5.76 0 (0%)

Fundamental Rating

2

AREN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 70 industry peers in the Interactive Media & Services industry. AREN has a bad profitability rating. Also its financial health evaluation is rather negative. AREN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year AREN was profitable.
In the past year AREN has reported a negative cash flow from operations.
In the past 5 years AREN always reported negative net income.
In the past 5 years AREN always reported negative operating cash flow.
AREN Yearly Net Income VS EBIT VS OCF VS FCFAREN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

AREN's Return On Assets of 5.82% is fine compared to the rest of the industry. AREN outperforms 77.14% of its industry peers.
Industry RankSector Rank
ROA 5.82%
ROE N/A
ROIC N/A
ROA(3y)-50.26%
ROA(5y)-50.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AREN Yearly ROA, ROE, ROICAREN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K 4K

1.3 Margins

AREN has a Profit Margin of 5.18%. This is in the better half of the industry: AREN outperforms 70.00% of its industry peers.
AREN's Operating Margin of 18.00% is amongst the best of the industry. AREN outperforms 84.29% of its industry peers.
AREN's Gross Margin of 48.50% is on the low side compared to the rest of the industry. AREN is outperformed by 64.29% of its industry peers.
AREN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18%
PM (TTM) 5.18%
GM 48.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.31%
GM growth 5Y31.33%
AREN Yearly Profit, Operating, Gross MarginsAREN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

0

2. Health

2.1 Basic Checks

AREN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AREN has been increased compared to 1 year ago.
Compared to 5 years ago, AREN has more shares outstanding
Compared to 1 year ago, AREN has a worse debt to assets ratio.
AREN Yearly Shares OutstandingAREN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AREN Yearly Total Debt VS Total AssetsAREN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -4.13, we must say that AREN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AREN (-4.13) is worse than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.13
ROIC/WACCN/A
WACC11.32%
AREN Yearly LT Debt VS Equity VS FCFAREN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

2.3 Liquidity

A Current Ratio of 0.33 indicates that AREN may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.33, AREN is doing worse than 97.14% of the companies in the same industry.
AREN has a Quick Ratio of 0.33. This is a bad value and indicates that AREN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of AREN (0.33) is worse than 95.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
AREN Yearly Current Assets VS Current LiabilitesAREN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

AREN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 101.10%, which is quite impressive.
The Revenue for AREN has decreased by -10.66% in the past year. This is quite bad
Measured over the past years, AREN shows a quite strong growth in Revenue. The Revenue has been growing by 18.74% on average per year.
EPS 1Y (TTM)101.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.05%
Revenue 1Y (TTM)-10.66%
Revenue growth 3Y-12.68%
Revenue growth 5Y18.74%
Sales Q2Q%9.95%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y123.58%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year71.95%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AREN Yearly Revenue VS EstimatesAREN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
AREN Yearly EPS VS EstimatesAREN Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2021 2022 2023 2024 2025 0 -1 -2 -3 -4

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 96.00, the valuation of AREN can be described as expensive.
AREN's Price/Earnings is on the same level as the industry average.
AREN is valuated expensively when we compare the Price/Earnings ratio to 28.05, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 19.47, which indicates a rather expensive current valuation of AREN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AREN indicates a somewhat cheap valuation: AREN is cheaper than 61.43% of the companies listed in the same industry.
AREN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 37.67, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 96
Fwd PE 19.47
AREN Price Earnings VS Forward Price EarningsAREN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

AREN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AREN is cheaper than 72.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.45
AREN Per share dataAREN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.78
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AREN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ARENA GROUP HOLDINGS INC/THE

NYSEARCA:AREN (7/28/2025, 4:15:01 PM)

After market: 5.76 0 (0%)

5.76

-0.34 (-5.57%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-12 2025-08-12
Inst Owners4.77%
Inst Owner Change-1.28%
Ins Owners1.41%
Ins Owner Change0.13%
Market Cap273.95M
Analysts82.86
Price TargetN/A
Short Float %6.64%
Short Ratio2.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 96
Fwd PE 19.47
P/S 2.13
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 12.45
EPS(TTM)0.06
EY1.04%
EPS(NY)0.3
Fwd EY5.14%
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS2.71
BVpS-2.65
TBVpS-4.18
PEG (NY)0.78
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.82%
ROE N/A
ROCE -452.6%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 18%
PM (TTM) 5.18%
GM 48.5%
FCFM N/A
ROA(3y)-50.26%
ROA(5y)-50.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.31%
GM growth 5Y31.33%
F-Score4
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 3.62
Cap/Depr 65.22%
Cap/Sales 4.72%
Interest Coverage 1.17
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z -4.13
F-Score4
WACC11.32%
ROIC/WACCN/A
Cap/Depr(3y)25.82%
Cap/Depr(5y)23.62%
Cap/Sales(3y)3.11%
Cap/Sales(5y)3.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.05%
EPS Next Y123.58%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.66%
Revenue growth 3Y-12.68%
Revenue growth 5Y18.74%
Sales Q2Q%9.95%
Revenue Next Year71.95%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y264.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year677.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-236.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3219.1%
OCF growth 3YN/A
OCF growth 5YN/A